Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01355653 · ClinicalTrials.gov registry record · NA
Heat Wrap Device Safety With Age and Body Fat
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT01355653: Completed NA study, sponsored by Pfizer.
NCT01355653 is a NA study that has completed, run by Pfizer. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01355653, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study is designed to compare the safety, as measured by skin findings and adverse events, of two different heat devices in elderly, overweight, and elderly and overweight subjects.
Interventions
- DEVICE thermal therapy
- DEVICE ThermaCare heatwrap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2011-05-05 |
| Est. Completion | 2011-07-28 |
| Phase | NA |
What the finished NCT01355653 record still lists
NCT01355653 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which thermal therapy is the first listed.
NCT01355653 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01355653 about?
NCT01355653 is a clinical study titled "Heat Wrap Device Safety With Age and Body Fat". This study is designed to compare the safety, as measured by skin findings and adverse events, of two different heat devices in elderly, overweight, and elderly and overweight subjects.
What is the current status of trial NCT01355653?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2011-05-05. Estimated completion is 2011-07-28.
What interventions are being tested in trial NCT01355653?
The interventions under investigation include: thermal therapy (DEVICE), ThermaCare heatwrap (DEVICE).
Who is sponsoring clinical trial NCT01355653?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01355653's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI